Day: January 5, 2022

SFIO announces $50-M eco-luxury community project in world-renowned Puerto Princesa, Palawan

Written by Customer Service on January 5, 2022. Posted in Public Companies.

With stunning views of Ulugan Bay, the eight-hectare seaside community will feature world-class resort amenities and pioneer health and wellness offerings in one of the world’s most iconic islands NEW YORK, Jan. 05, 2022 (GLOBE NEWSWIRE) — Last month, global asset management company Starfleet Innotech, Inc. (OTC: SFIO) closed off 2021 by signing a joint venture with Filipino partners to build a world-class eco-luxury, health and wellness community on their bayside property in globally-renowned Philippine destination Puerto Princesa, Palawan. The project will be owned and developed by SFIO Leisure and Development, Inc., a joint venture stock corporation, and will see eight hectares of beachfront land transformed into an exclusive, holistic lifestyle community hidden amongst Palawan’s iconic mangrove glades and situated less than...

Zosano Pharma Announces Publication of Clinical Data Demonstrating Comparable Immunogenicity of a Trivalent Influenza Vaccine Formulated on its Transdermal Microneedle System Versus an Intramuscular Injection of the Vaccine at a Higher Dose

Written by Customer Service on January 5, 2022. Posted in Public Companies.

—Data published in the Journal of Vaccines and Immunology— FREMONT, Calif., Jan. 05, 2022 (GLOBE NEWSWIRE) — Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced the publication of Phase 1 clinical trial data in an article titled, “Immunogenicity and Safety of Inactivated Influenza Split-Virion Vaccine Administered via a Transdermal Microneedle System” in the Journal of Vaccines and Immunology. The data demonstrated that a low dose of a trivalent influenza vaccine administered via its transdermal microneedle system produced antibody levels that met EMEA’s three guidelines for influenza vaccine efficacy and was generally well tolerated. “We are excited to report these results, which show that a lower dose of an influenza vaccine administered using our transdermal microneedle system...

Dassault Systèmes: Declaration of the number of outstanding shares and voting rights as of December 31, 2021

Written by Customer Service on January 5, 2022. Posted in Public Companies.

Press ReleaseVELIZY-VILLACOUBLAY, France — January 5, 2022 Declaration of the number of outstanding shares and voting rights as of December 31, 2021 Dassault Systèmes (Euronext Paris: FR0014003TT8, DSY.PA) today announced below the total number of its outstanding shares and voting rights as of December 31, 2021, according to articles 223-16 and 221-3 of the General Regulation of the Autorité des marchés financiers. Number of outstanding shares: 1,332,716,653 Number of voting rights*: 1,993,244,071 *The total number of voting rights is calculated on the basis of the total number of outstanding shares, even if the voting rights attached thereto are suspended, pursuant to Article 223-11 of the General Regulation of the Autorité des marchés financiers relating to the method for calculating the percentages of holdings in shares and in voting...

Albireo Increases 2021 Bylvay™ (odevixibat) Sales Guidance

Written by Customer Service on January 5, 2022. Posted in Public Companies.

– Bylvay net sales guidance revised to $6-7M vs. expectations of $3-4M – Unaudited cash of at least $248M, updates guidance with cash into 2024 – BOLD Phase 3 study in biliary atresia is over 50% enrolled – ASSERT Phase 3 study in Alagille syndrome on track for topline data by end of year BOSTON, Jan. 05, 2022 (GLOBE NEWSWIRE) — Albireo Pharma, Inc. (Nasdaq: ALBO), a rare liver disease company developing novel bile acid modulators, updated guidance for Bylvay net sales, cash and the two Phase 3 clinical studies. Global Bylvay net sales in 2021 are expected to be $6-7 million, higher than previous guidance of $3-4 million. Unaudited cash and cash equivalents as of December 31, 2021 was at least $248 million, and the Company expects to have sufficient cash into 2024 based on current revenue and expense projections. Albireo has two...

Verisk Earns Sixth Consecutive Great Place to Work Certification™

Written by Customer Service on January 5, 2022. Posted in Public Companies.

Great Place to Work BadgeUS CertificationJERSEY CITY, N.J., Jan. 05, 2022 (GLOBE NEWSWIRE) — For the sixth consecutive year, leading global data analytics provider Verisk (NASDAQ: VRSK) is Certified™ in the United States by Great Place to Work. Based on employee feedback, the certification honors Verisk for its outstanding workplace culture. Verisk’s certification is driven by an employee engagement survey which measured the extent to which employees across the organization reported a consistently great workplace experience, considering factors such as their daily encounters of innovation, inclusivity, company values and the effectiveness of its leaders. The survey found that 83% of Verisk teammates say it is a great place to work, compared to 59% of employees at the average U.S.-based company, and 92% agree that...

Intrado Acquires Permission Click

Written by Customer Service on January 5, 2022. Posted in Mergers And Acquisitions.

Integrating Permission Click with existing Intrado Life & Safety digital workflow tools will accelerate the digital transformation for K-12 education ISLANDIA, N.Y., Jan. 05, 2022 (GLOBE NEWSWIRE) — Intrado Corporation (“Intrado”), a global leader in technology-enabled services, announced today that it has acquired Permission Click, a pioneer in education technology. With this acquisition, Intrado Life & Safety expands its leadership position in K-12 education technology, adding Permission Click’s digital workflow solutions to its SchoolMessenger communications suite of solutions. Permission Click’s innovative product enables schools and school districts to digitize previously manual processes and forms management, increasing efficiency, transparency, and policy compliance, in addition to saving time for parents and teachers....

Digerati Closes Acquisition of SkyNet Telecom

Written by Customer Service on January 5, 2022. Posted in Mergers And Acquisitions.

– Expands Cloud Communication and Broadband Solutions Footprint in Texas – – Adds $3.4 Million in Annual Revenue – SAN ANTONIO, Jan. 05, 2022 (GLOBE NEWSWIRE) — Digerati Technologies, Inc. (OTCQB: DTGI) (“Digerati” or the “Company”), a provider of cloud services specializing in UCaaS (Unified Communications as a Service) solutions for the small to medium-sized business (“SMB”) market, is pleased to announce the completion of the acquisition of San Antonio-based SkyNet Telecom (“SkyNet”), a leading provider of cloud communication and broadband solutions tailored for businesses. The acquisition of SkyNet expands the Company’s footprint in Texas and increases its customer base by over 215% to 737 business customers in the Lone Star State. On a consolidated basis and as a result of this acquisition, Digerati’s...

Surgalign Holdings, Inc. Expands Digital Health Capabilities with Acquisition of a Significant Equity Interest in Inteneural Networks Inc.

Written by Customer Service on January 5, 2022. Posted in Mergers And Acquisitions.

Artificial Intelligence Technology Will Enable Computers to Autonomously Identify and Segment Neural Structures in Medical Images and Provide Reference Information Regarding Pathological States DEERFIELD, Ill., Jan. 05, 2022 (GLOBE NEWSWIRE) — Surgalign Holdings, Inc. (NASDAQ: SRGA), a global medical technology company focused on elevating the standard of care through the evolution of digital health, today announced it has acquired an equity interest in Inteneural Networks Inc. (“INN”), and its proprietary artificial intelligence (AI) technology for autonomously segmenting and identifying neural structures in medical images and helping identify possible pathological states. The Company will also have the ability to acquire the remainder of INN’s outstanding equity interests upon the achievement of certain regulatory, developmental,...

PartnerOne Completes the Acquisition of Evolving Systems

Written by Customer Service on January 5, 2022. Posted in Mergers And Acquisitions.

ENGLEWOOD, Colo., Jan. 05, 2022 (GLOBE NEWSWIRE) — Evolving Systems Inc. (Nasdaq: EVOL), the leader in real-time digital engagement solutions and services, has announced that its previously reported pending acquisition by PartnerOne has been completed. Under the terms of the agreement, PartnerOne has acquired all of the assets of Evolving Systems’ Customer Acquisition and Network Services division (‘Activation’) as well as its CVML and Loyalty business (‘Marketing’). Evolving Systems is a real-time digital engagement accelerator with 100+ major customers across 5 continents. For over thirty years, Evolving Systems’ products and services have empowered Communications Service Providers (CSPs) to increase revenue per user, reduce friction, improve retention and maximize customer satisfaction. Many of the world’s largest telecommunications...

Aeterna Zentaris to Present at the H.C. Wainwright BioConnect Conference

Written by Customer Service on January 5, 2022. Posted in Public Companies.

CHARLESTON, S.C., Jan. 05, 2022 (GLOBE NEWSWIRE) — Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (“Aeterna” or the “Company”), a specialty biopharmaceutical company developing and commercializing a diversified portfolio of pharmaceutical and diagnostic products, today announced that Dr. Klaus Paulini, Chief Executive Officer of Aeterna Zentaris, will present at the virtual H.C. Wainwright BioConnect Conference taking place January 10-13, 2022. A video webcast of the presentation will be available for viewing on-demand beginning Monday, January 10, 2022, at 7:00 AM ET for those registered for the event and will be accessible on the Events page in the Investors section of the Company’s website (www.zentaris.com). The webcast replay will be archived for 90 days following the event. About Aeterna Zentaris Inc. Aeterna Zentaris is...

Day: January 5, 2022

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice